Bladder Cancer

>

CURE’s bladder cancer page is a go-to resource for oncology news and updates in the world of bladder cancer. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in bladder cancer.

Latest News

Patients with high-risk bladder cancer reported similar QOL when treated with sasanlimab plus BCG versus BCG alone: © stock.adobe.com.
Bladder Cancer Patients Maintain Quality of Life With Sasanlimab Combo

July 23rd 2025

Patients with high-risk bladder cancer reported similar quality of life when treated with sasanlimab plus BCG versus BCG alone, new study data showed.

Zusduri had a median response duration of 3.5 years and event-free survival of two years in low-grade intermediate-risk bladder cancer: © stock.adobe.com.
Zusduri Shows Durable Responses in Some Bladder Cancers

July 21st 2025

FDA grants priority review to TAR-200 for high-risk bladder cancer unresponsive to BCG: © stock.adobe.com.
FDA Grants Priority Review to TAR-200 for Bladder Cancer Subset

July 18th 2025

Image of clinical trial.
New Trials Target Brain, Bladder, Ovarian and Other Cancers

July 7th 2025

Image of chester.
Reflections After Nine Years as a Bladder Cancer Survivor

July 3rd 2025

Video Series
Video Interviews
Podcasts
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
cancer horizons podcast logo
Peter Kahan and his oncologist and former student, Dr. Ravi Munver smiling and standing outside Hackensack University Medical Center |   Photo courtesy Hackensack University Medical Center

More News